by Weizmann Institute of Science Cancer cells are comfy havens for bacteria. That conclusion arises from a rigorous study of over 1,000 tumor samples of different human cancers. The study, headed by researchers at the Weizmann Institute of Science, found bacteria living inside the cells of all the cancer types—from brain to bone to breast...
by Kanazawa University Researchers at Kanazawa University report in the Journal of Thoracic Oncology a promising novel approach for a combined treatment of the most common type of lung cancer and associated secondary cancers in the central nervous system. The approach lies in combining two cancer drugs, with one compensating for a resistance side effect...
by Katie Willis, University of Alberta Credit: CC0 Public Domain Researchers at the University of Alberta have discovered a new class of drugs with the potential to make cancer treatment safer and more effective by preventing cancer cells from repairing themselves. “For patients with resistant cancer, these drugs could rescue them by rendering their cancer once again...
The benefits of a diet high in fiber and yogurt have already been established for cardiovascular disease and gastrointestinal cancer. The new findings, based on an analysis of data from studies involving 1.4 million adults in the United States, Europe, and Asia, suggest this diet may also protect against lung cancer. Researchers divided participants into...
VANDERBILT UNIVERSITY MEDICAL CENTER A diet high in fiber and yogurt is associated with a reduced risk for lung cancer, according to a study by Vanderbilt University Medical Center researchers published in JAMA Oncology. IMAGE: SENIOR AUTHOR XIAO-OU SHU, MD, PHD, MPH, INGRAM PROFESSOR OF CANCER RESEARCH, ASSOCIATE DIRECTOR FOR GLOBAL HEALTH AND CO-LEADER OF...
by Cancer Research UK Early signs that a patient’s lung cancer may spread and become untreatable can be picked up in samples of their blood and tumour, according to a trio of papers published in Nature Medicine today. The three studies are all part of Cancer Research UK’s £14million TRACERx project, which aims to understand...
by Andrea Laferle, University of Michigan Changing the way individuals are selected to be screened for lung cancer, by considering their probability of getting or dying from lung cancer calculated from risk-prediction models, could prevent 14 percent of lung cancer deaths per year. The Cancer Intervention and Surveillance Modeling Network Lung Working Group (CISNET), which...
Pegilodecakin with pembrolizumab and nivolumab shown to be safe in Phase 1B study UNIVERSITY OF TEXAS M. D. ANDERSON CANCER CENTER HOUSTON — Pegilodecakin, a first-in-class drug currently in clinical trials, has shown positive safety results and may offer a potential new treatment avenue for patients with non-small cell lung cancer (NSCLC) and kidney cancer....
by European Society for Medical Oncology An electronic nose that detects chemicals in the breath of lung cancer patients can identify with 85% accuracy those who will or will not respond to immunotherapy, according to new research published in the leading cancer journal Annals of Oncology today. The results of the first study to investigate this...
INTERNATIONAL ASSOCIATION FOR THE STUDY OF LUNG CANCER Barcelona–Researchers reported today that a prospective trial comparing two screening methods for at-risk lung cancer patients found that a model used by Canadian, Australian and European public health organizations detected more cancers than the screening model used by the United States Preventive Services Task Force (USPSTF). The...
